Content area
Abstract
An international security conference explored how artificial intelligence (AI) technologies for drug discovery could be misused for de novo design of biochemical weapons. A thought experiment evolved into a computational proof.
Details
Title
Dual use of artificial-intelligence-powered drug discovery
Author
Urbina Fabio 1 ; Lentzos Filippa 2 ; Invernizzi Cédric 3
; Ekins, Sean 1
1 Collaborations Pharmaceuticals, Inc., Raleigh, USA (GRID:grid.492575.8)
2 King’s College London, Department of War Studies and Department of Global Health & Social Medicine, London, UK (GRID:grid.13097.3c) (ISNI:0000 0001 2322 6764)
3 Civil Protection and Sports, Spiez Laboratory, Federal Department of Defence, Spiez, Switzerland (GRID:grid.482328.7) (ISNI:0000 0004 0516 7352)
; Ekins, Sean 1
1 Collaborations Pharmaceuticals, Inc., Raleigh, USA (GRID:grid.492575.8)
2 King’s College London, Department of War Studies and Department of Global Health & Social Medicine, London, UK (GRID:grid.13097.3c) (ISNI:0000 0001 2322 6764)
3 Civil Protection and Sports, Spiez Laboratory, Federal Department of Defence, Spiez, Switzerland (GRID:grid.482328.7) (ISNI:0000 0004 0516 7352)
Pages
189-191
Publication year
2022
Publication date
Mar 2022
e-ISSN
25225839
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2641736775
Copyright
© Springer Nature Limited 2022.